Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Different flames, different fates : A comparative study of surgical interventions and critical care burden in electrical vs. thermal burn injuries.

Wiener klinische Wochenschrift·2026
Same author

Reply to the Letter Regarding "Neuroendocrine Deficits and Weight Development Before and After Proton Therapy in Children With Craniopharyngioma".

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Neuroendocrine Deficits and Weight Development Before and After Proton Therapy in Children With Craniopharyngioma.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

CNS Embryonal Tumor with PLAGL Amplification, a New Tumor in Children and Adolescents: Insights from a Comprehensive MRI Analysis.

AJNR. American journal of neuroradiology·2024
Same author

Comparison of the level of physical activity after the COVID-19 pandemic in Poland, Slovakia and the Czech Republic.

BMC sports science, medicine & rehabilitation·2024
Same author

MR Imaging and Clinical Characteristics of Diffuse Glioneuronal Tumor with Oligodendroglioma-like Features and Nuclear Clusters.

AJNR. American journal of neuroradiology·2022
Same journal

Antiangiogenic therapies in gastric cancer: future directions for 2026 and beyond: an UNICANCER gastrointestinal group (UCGI) perspective.

Cancer treatment reviews·2026
Same journal

Treatment of breast cancer brain metastases in the era of novel drugs.

Cancer treatment reviews·2026
Same journal

Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck.

Cancer treatment reviews·2026
Same journal

Precision targeting of CLDN18.2: A new therapeutic paradigm for gastric cancer.

Cancer treatment reviews·2026
Same journal

Beyond body surface area: CT-derived body composition as a predictor of chemotherapy toxicity and survival in pancreatic ductal adenocarcinoma: a systematic review.

Cancer treatment reviews·2026
Same journal

Early onset pancreatic Cancer: epidemiology, molecular features, and clinical outcomes.

Cancer treatment reviews·2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.0K

Recent developments and current concepts in medulloblastoma.

N U Gerber1, M Mynarek2, K von Hoff2

  • 1Department of Oncology, University Children's Hospital, CH-8032 Zurich, Switzerland.

Cancer Treatment Reviews
|January 7, 2014
PubMed
Summary
This summary is machine-generated.

Medulloblastoma, a common childhood brain tumor, has improved survival rates due to multimodal therapy. However, research is ongoing for better treatments and reduced side effects in difficult cases.

Keywords:
(MeSH): MedulloblastomaBrain neoplasmsCancerChildMolecular targeted therapyTherapy

More Related Videos

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

11.6K
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

2.1K

Related Experiment Videos

Last Updated: May 4, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.0K
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

11.6K
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

2.1K

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Cancer Research

Background:

  • Medulloblastoma is the most frequent malignant brain tumor in children.
  • Current multimodal therapy (surgery, radiotherapy, chemotherapy) has improved outcomes, but one-third of patients still have a poor prognosis.
  • There is a critical need for novel therapeutic strategies to improve survival and minimize long-term treatment complications.

Purpose of the Study:

  • To review current treatment strategies for medulloblastoma.
  • To provide an outlook on future therapeutic directions.
  • To discuss recent advances in understanding molecular mechanisms and their clinical applications.

Main Methods:

  • Literature review of current medulloblastoma treatment concepts.
  • Analysis of recent research on molecular mechanisms underlying medulloblastoma.
  • Discussion of potential impact on risk stratification and targeted therapy implementation.

Main Results:

  • Multimodal therapy has enhanced prognosis, yet challenges remain for high-risk groups.
  • Advances in understanding molecular drivers offer new avenues for treatment.
  • Potential for improved risk stratification and targeted therapies in clinical practice.

Conclusions:

  • Despite progress, medulloblastoma treatment requires further optimization for unfavorable patient groups.
  • Molecular insights are crucial for developing more effective and less toxic therapies.
  • Future strategies will likely involve targeted therapies informed by a deeper understanding of tumor biology.